FDA Inspection 1291316 — Takeda Austria GmbH
The FDA completed an inspection of Takeda Austria GmbH on Sep 11, 2025 in Linz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Linz (Austria)